Inventaire


Site en français

MAPK pathway as a target for therapy in melanoma.

Units : Laboratory of Oncology and Experimental Surgery | ULB305



Description :


The project investigates new machanisms to overcome MAPK pathway inhibitors in BRAF or NRAS mutated melanomas.

List of persons in charge :


  • GHANEM Ghanem Elias

  • JOURNE Fabrice


List of lessors :


  • Télévie

  • Entreprises privées